You are here

  • Home
  • Archive
  • Volume 31, Issue 6
  • Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

Citation Tools

Article menu
Download PDFPDF
Letter
Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Concin N, Matias-Guiu X, Creutzberg CL on behalf of the ESGO-ESTRO-ESP Endometrial Carcinoma Guideline Working Group
Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?
International Journal of Gynecologic Cancer 2021;31:947.